Correlation Between Pfizer and Mersana Therapeutics
Can any of the company-specific risk be diversified away by investing in both Pfizer and Mersana Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pfizer and Mersana Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pfizer Inc and Mersana Therapeutics, you can compare the effects of market volatilities on Pfizer and Mersana Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pfizer with a short position of Mersana Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pfizer and Mersana Therapeutics.
Diversification Opportunities for Pfizer and Mersana Therapeutics
-0.59 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Pfizer and Mersana is -0.59. Overlapping area represents the amount of risk that can be diversified away by holding Pfizer Inc and Mersana Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mersana Therapeutics and Pfizer is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pfizer Inc are associated (or correlated) with Mersana Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mersana Therapeutics has no effect on the direction of Pfizer i.e., Pfizer and Mersana Therapeutics go up and down completely randomly.
Pair Corralation between Pfizer and Mersana Therapeutics
Considering the 90-day investment horizon Pfizer is expected to generate 48.45 times less return on investment than Mersana Therapeutics. But when comparing it to its historical volatility, Pfizer Inc is 4.17 times less risky than Mersana Therapeutics. It trades about 0.0 of its potential returns per unit of risk. Mersana Therapeutics is currently generating about 0.05 of returns per unit of risk over similar time horizon. If you would invest 197.00 in Mersana Therapeutics on September 12, 2024 and sell it today you would earn a total of 71.00 from holding Mersana Therapeutics or generate 36.04% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Pfizer Inc vs. Mersana Therapeutics
Performance |
| Timeline |
| Pfizer Inc |
| Mersana Therapeutics |
Pfizer and Mersana Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Pfizer and Mersana Therapeutics
The main advantage of trading using opposite Pfizer and Mersana Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pfizer position performs unexpectedly, Mersana Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mersana Therapeutics will offset losses from the drop in Mersana Therapeutics' long position.| Pfizer vs. Victory Integrity Smallmid Cap | Pfizer vs. Hilton Worldwide Holdings | Pfizer vs. NVIDIA | Pfizer vs. JPMorgan Chase Co |
| Mersana Therapeutics vs. Terns Pharmaceuticals | Mersana Therapeutics vs. Amylyx Pharmaceuticals | Mersana Therapeutics vs. Acumen Pharmaceuticals | Mersana Therapeutics vs. Inozyme Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
Other Complementary Tools
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios |